Boca Raton Regional Hospital has been named a 2015/2016 Consumer Choice Award recipient by the National Research Corporation (NRC). The annual accolade identifies hospitals across the United States that healthcare consumers choose as having the highest quality and image. Boca Regional joins such prestigious institutions as the Hospital of the University of Pennsylvania, Massachusetts General Hospital and The Johns Hopkins Hospital in this year’s listings, and is the only provider in Palm Beach County to receive the distinction.
Robert Levy, MD, PhD, Director of the Marcus Neuroscience Institute (MNI) at Boca Raton Regional Hospital is the first physician in the state of Florida to use the latest and most advanced form of spinal cord stimulation (SCS) as a method to treat patients with chronic back and leg pain. The Senza® SCS system, developed by Nevro Corporation, is a spinal cord stimulator that has demonstrated superior results as compared to standard stimulation systems, with patients achieving approximately a 50% greater improvement in pain score than those with traditional SCS therapy.
Pain in general is the most common reason for physician visits in the United States. Chronic pain can significantly interfere with a person’s quality of life and functionality. There are a variety of treatment options for chronic pain that range from medications to surgical interventions.
Boca Raton Regional Hospital’s Richard G. Cartledge, MD, FACS, has begun performing ultra-minimally invasive left atrial appendage ligation for atrial fibrillation patients who are on anticoagulants such as Coumadin, Xarelto or Effient. Dr. Cartledge, who is Chief of Cardiothoracic Surgery at the Hospital, is one of a select group of surgeons nationally using this method, which involves making two microscopic incisions in order to seal off the left atrial appendage (LAA) in patients where anticoagulants are contraindicated or who refuse to be on such medications.
Palm Beach County‘s life science industry — controversial for the amount of tax dollars sunk into it more than a decade ago — will be put under a microscope for potential expansion.
Business Development Board president Kelly Smallridge on Tuesday unveiled an effort aimed at expanding the county’s life science businesses.
The economic development group is “going back to the table to inventory the county’s life science assets,” Smallridge said.
A $55,000 study by Maryland-based Facility Logix will help the Business Development Board understand the assets of the life science sector and identify gaps to better market the county, she said.
The county’s biotech sector includes Scripps Florida and the Max Planck Florida Institute for Neuroscience in Jupiter, about 200 biotech companies, hospitals, and educational programs including Scripps, Max Planck and Florida Atlantic University’s School of Medicine.
Now that Florida’s economy has essentially recovered from the recession, Smallridge said it’s time for economic officials to make a bigger play for science-related businesses as well as figure how to keep spin-off companies from the institutes in the area.